State of Coagulation in Pre-eclampsia: Comparing Sonoclot Signature Analysis With Conventional and Specific Haemostasis Assays
NCT05625763 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 55
Last updated 2022-11-23
Summary
* Detection of the presence or absence of coagulopathy in cases with pre-eclampsia.
* Investigate the value of global hemostasis studies (Sonoclot signature analysis) in cases of pre-eclampsia and if there a correlation between it and the specific traditional assays of hemostasis.
Conditions
- Pre-Eclampsia
Interventions
- DIAGNOSTIC_TEST
-
sonoclot signature analysis
Investigate the value of global hemostasis studies (Sonoclot signature analysis) in cases of pre-eclampsia and if there a correlation between it and the specific traditional assays of hemostasis.
Sponsors & Collaborators
-
Assiut University
lead OTHER
Eligibility
- Min Age
- 18 Years
- Max Age
- 45 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-11-15
- Primary Completion
- 2024-11-29
- Completion
- 2024-12-29
More Related Trials
-
Predicting Late-onset Preeclampsia at 10-14 Weeks of Pregnancy
NCT04075708 ·Status: COMPLETED
-
Thromboelastogram in Postdelivery Preeclamptic Patients
NCT03555630 ·Status: COMPLETED
-
MorbiMortality Amelioration in Preeclamptic Primiparas Study. MoMA Pre Prim Study
NCT00763672 ·Status: COMPLETED ·Phase: NA
-
Evaluation of sFlt-1/PlGF Ratio ,OPG and sEng as Predictive Biomarkers in the Diagnosis and Treatment Evaluation of Preeclampsia
NCT07349277 ·Status: RECRUITING
-
Serum Soluble Endoglin and Matrix Metalloproteinase 14 With Elisa Method in Early/Late-onset Preeclampsia
NCT03932877 ·Status: COMPLETED
-
The Study of Cardiovascular Outcomes in Women With Preeclampsia Using Echocardiography: The SCOPE Study
NCT02357667 ·Status: COMPLETED
-
Perinatal Outcomes and Hematologic Parameters in COVID-19 Pregnancies
NCT04515108 ·Status: COMPLETED
-
Perinatal Outcomes in Patients With Elevated sFlt-1/PlGF Ratio
NCT06403722 ·Status: COMPLETED
-
Study of Coagulation Activation Markers and Pre Eclampsia
NCT01261351 ·Status: COMPLETED
-
Improved Characterisation of Eclampsia
NCT05199558 ·Status: UNKNOWN
-
THROmbinography in Pregnant Woman and in Vitro Action of Low Molecular Weight HEparin
NCT06575309 ·Status: RECRUITING
-
Evaluation of the Serum Markers sFLt1 and PlGF for the Prediction of the Complications of the Placental Vascular Pathologies in the 3rd Quarter of the Pregnancy.
NCT03455387 ·Status: COMPLETED
-
Pre-Eclampsia Prediction By Doppler Screening Of Uterine Arteries And Angiogenic Factors In Second Trimester Of Pregnancy
NCT00725660 ·Status: UNKNOWN
-
Prediction of Early Pre-eclampsia From Maternal Factors, Biophysical and Biochemical Markers at First Trimester
NCT02990767 ·Status: UNKNOWN
-
Prospective Study on Feto-maternal outcoMe In aNemIc womEn
NCT05739097 ·Status: UNKNOWN
-
Molecular Study of the Maternal-fetal Interface in Preeclampsia.
NCT06232668 ·Status: RECRUITING
-
Covid-19 Infection in Pregnancy
NCT04869202 ·Status: COMPLETED
-
GROSS-HIST : Quantification of the Main Circulating Histones During Normal Pregnancy and Pregnancies With Placenta-mediated Complications
NCT04205383 ·Status: COMPLETED
-
Patients Pregnant Women With or Without Primary Antiphospholipid Antibody Syndrome
NCT05786235 ·Status: RECRUITING
-
Pregnancy and Fibrin Clot Properties
NCT07275476 ·Status: RECRUITING
-
Role of Vaspin in Pathophysiology of Pre-eclampsia
NCT06437535 ·Status: NOT_YET_RECRUITING
-
Free DNA and Nucleosome Concentrations in Pathological Pregnancies
NCT01736826 ·Status: COMPLETED
-
Women's Perspective on First-trimester Preeclampsia Screening
NCT05123560 ·Status: UNKNOWN
-
Are Serum Levels of Vascular Endothelial Growth Factor a Marker for the Early Diagnosis of Ectopic Pregnancy?
NCT01261026 ·Status: COMPLETED
-
Precision Medicine for Prediction & Prevention of Early Pre-eclampsia
NCT04412681 ·Status: UNKNOWN ·Phase: NA